Clinical Trial Update: Nordic Adjuvant IFN Melanoma Trial [Phase 3]

View source ↗

Summary

The Nordic adjuvant interferon melanoma trial (Phase 3) has completed. This is a status update indicating the Phase 3 study has finished.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Melanoma

Drugs mentioned

• Interferon (IFN) (Interferon)

Snippet

Sponsor: Karolinska Institutet | Conditions: Melanoma, Adjuvant Therapy | Phase 3 | Status: COMPLETED